NCT07475650Completed
Virtual Reality in ICU Patients With COPD
The Effect of Virtual Reality Glasses Application on Sleep Quality, Anxiety and Vital Signs in Intensive Care Patients With COPD
Source: ClinicalTrials.gov · Last updated 16 Mar 2026
Brief summary (registry, in English)
This study aims to evaluate the effect of a virtual reality glasses application on sleep quality, anxiety, and vital signs in patients with chronic obstructive pulmonary disease hospitalized in the intensive care unit. The study was conducted as a randomized controlled intervention study with 50 patients (25 experimental and 25 control) in the 2nd and 3rd level general intensive care units of Kayseri State Hospital. Patients in the experimental group received a 30 minute virtual reality session every evening for one week, while the control group received routine care. Sleep quality was assessed daily using the Richard-Campbell Sleep Scale, and anxiety levels were measured using the Beck Anxiety Scale. Vital signs were recorded before and after each VR session.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 50 (actual)
- First submitted
- 7 Mar 2026
- Start date
- 29 Nov 2022
- Primary completion date
- 28 Jan 2024
- Lead sponsor
- TC Erciyes University
- Diseases
- COPD
- NCT number
- NCT07475650
What you commit to
- Study type: Interventional
- Participants enrolled: 50
- From 29 Nov 2022 to the primary completion date, 28 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients receiving invasive or non-invasive mechanical ventilation
- Discontinuation Criteria:
- Initiation of any medication that affects sleep
- Initiation of medication for anxiety or sedation
Other
- Patients with a Richmond Agitation-Sedation Scale (RASS) score less than -1
- Experience problems with the virtual reality headset or report feeling unwell during the intervention
- Requirement for intubation
- Need for Continuous Positive Airway Pressure (CPAP) or Bilevel Positive Airway Pressure (BPAP) during the virtual reality intervention
Who the study is looking for
- Conscious and oriented, able to cooperate
- Aged 18 years and older
- Diagnosed with COPD according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2022 criteria (Stage II, Stage III, or Stage IV)
- Hospitalized in the intensive care unit for at least 24 hours in order to evaluate sleep problems
- No history of psychiatric disorders or cognitive impairment
- No complaints such as migraine, dizziness, active nausea, vomiting, or headache
- No visual, hearing, or cognitive impairments
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Faculty of Health Sciences Erciyes University Coordinator of this site? Confirm its status | Kayseri | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.